The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
A pilot study of omalizumab to facilitate rapid oral desensitization in high-risk peanut-allergic patients
Open accessAbstract
Background Peanut allergy is a major public health problem that affects 1% of the population and has no effective therapy. Objective To examine the safety and efficacy of oraldesensitization in peanut allergic children in combination with a brief course of anti-IgE monoclonal antibody (omalizumab, Xolair). Methods We performed oral peanut desensitization in peanut allergic children at high risk for developing significant peanut-induced allergic reactions. Omalizumab was administered prior to and during oral peanut desensitization. Results We enrolled 13 children (median age, 10 years), with a median peanut-specific IgE of 229 kUA/L and a median total serum IgE of 621 kU/L, who failed an initial double-blind placebo controlled food challenge at doses 100 mg peanut flour. After pre-treatment with omalizumab, all subjects tolerated the initial 11 desensitization doses given on the first day, including the maximum dose of 500 mg peanut flour (cumulative dose, 992 mg, equivalent to >2 peanuts), requiring minimal or no rescue therapy. 12 subjects then reached the maximum maintenance dose of 4,000 mg peanut flour/day in a median time of 8 weeks, at which point omalizumab was discontinued. All 12 subjects continued on 4,000 mg peanut flour/day and subsequently tolerated a challenge with 8,000 mg peanut flour (equivalent to about 20 peanuts), or 160 to 400 times the dose tolerated before desensitization. During the study, 6 of the 13 subjects experienced mild or no allergic reactions; 6 subjects had Grade 2, and 2 subjects Grade 3 reactions, all of which responded rapidly to treatment. Conclusions Among children with high-risk peanut allergy, treatment with omalizumab may facilitate rapid oral desensitization, and qualitativelyimprove the desensitization process.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Burks, A. W., James, J. M., & Eigenmann, P. (1951) · Cited by 2,562
Fatalities due to anaphylactic reactions to foods
Bock, S. A., Muñoz-Furlong, A., & Sampson, H. A. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.112031 · Cited by 1,566
Sicherer, S. H., & Sampson, H. A. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.08.028 · Cited by 974
US prevalence of self-reported peanut, tree nut, and sesame allergy: 11-year follow-up
Sicherer, S. H., Muñoz-Furlong, A., Godbold, J. H., & Sampson, H. A. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.03.029 · Cited by 932
Factors Associated with the Development of Peanut Allergy in Childhood
Lack, G., Fox, D., Northstone, K., & Golding, J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa013536 · Cited by 911
MacGlashan, D. W., Bochner, B. S., Adelman, D. C., Jardieu, P. M., Togias, A., McKenzie-White, J., Sterbinsky, S. A., Hamilton, R. G., & Lichtenstein, L. M. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.3.1438 · Cited by 823
Clinical efficacy and immune regulation with peanut oral immunotherapy
Jones, S. M., Pons, L., Roberts, J. L., Scurlock, A. M., Perry, T. T., Kulis, M., Shreffler, W. G., Steele, P., Henry, K. A., Adair, M., et al. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.05.022 · Cited by 715
Double-blind, placebo-controlled food challenge (DBPCFC) as an office procedure: A manual
Allan Bock, S., Sampson, H. A., Atkins, F. M., Zeiger, R. S., Lehrer, S., Sachs, M., Bush, R. K., & Metcafe, D. D. (1988) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(88)90135-2 · Cited by 714
Oral Immunotherapy for Treatment of Egg Allergy in Children
Burks, A. W., Jones, S. M., Wood, R. A., Fleischer, D. M., Sicherer, S. H., Lindblad, R. W., Stablein, D., Henning, A. K., Vickery, B. P., Liu, A. H., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200435 · Cited by 700
Effect of Anti-IgE Therapy in Patients with Peanut Allergy
Leung, D. Y. M., Sampson, H. A., Yunginger, J. W., Burks, A. W., Schneider, L. C., Wortel, C. H., Davis, F. M., Hyun, J. D., & Shanahan, W. R. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022613 · Cited by 691
Self-citation
Cited by
Food allergy: Epidemiology, pathogenesis, diagnosis, and treatment
Sicherer, S. H., & Sampson, H. A. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.11.020 · Cited by 1,346
Food allergy: immune mechanisms, diagnosis and immunotherapy
Yu, W., Freeland, D. M. H., & Nadeau, K. C. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.111 · Cited by 659
International consensus on (ICON) anaphylaxis
Simons, F. E. R., Ardusso, L. R. F., Bilò, M. B., Cardona, V., Ebisawa, M., El-Gamal, Y. M., Lieberman, P., Lockey, R. F., Muraro, A., Roberts, G., et al. (2014) · World Allergy Organization Journal · doi:10.1186/1939-4551-7-9 · Cited by 479
Wood, R. A., Kim, J. S., Lindblad, R., Nadeau, K., Henning, A. K., Dawson, P., Plaut, M., & Sampson, H. A. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.10.005 · Cited by 390
Fajt, M. L., & Wenzel, S. E. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.12.1871 · Cited by 353
Omalizumab facilitates rapid oral desensitization for peanut allergy
MacGinnitie, A. J., Rachid, R., Gragg, H., Little, S. V., Lakin, P., Cianferoni, A., Heimall, J., Makhija, M., Robison, R., Chinthrajah, R. S., et al. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.08.010 · Cited by 327
Self-citationEpicutaneous immunotherapy for the treatment of peanut allergy in children and young adults
Jones, S. M., Sicherer, S. H., Burks, A. W., Leung, D. Y. M., Lindblad, R. W., Dawson, P., Henning, A. K., Berin, M. C., Chiang, D., Vickery, B. P., et al. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.08.017 · Cited by 314
Molecular and cellular mechanisms of food allergy and food tolerance
Chinthrajah, R. S., Hernandez, J. D., Boyd, S. D., Galli, S. J., & Nadeau, K. C. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.02.004 · Cited by 307
Han, H., Roan, F., & Ziegler, S. F. (2017) · Immunological Reviews · doi:10.1111/imr.12546 · Cited by 285
Andorf, S., Purington, N., Block, W. M., Long, A. J., Tupa, D., Brittain, E., Rudman Spergel, A., Desai, M., Galli, S. J., Nadeau, K. C., et al. (2018) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(17)30392-8 · Cited by 261
Bégin, P., Dominguez, T., Wilson, S. P., Bacal, L., Mehrotra, A., Kausch, B., Trela, A., Tavassoli, M., Hoyte, E., O’Riordan, G., et al. (2014) · Allergy, Asthma & Clinical Immunology · doi:10.1186/1710-1492-10-7 · Cited by 239
Food allergy in children—the current status and the way forward
Elghoudi, A., & Narchi, H. (2022) · World Journal of Clinical Pediatrics · doi:10.5409/wjcp.v11.i3.253 · Cited by 75
Novel Biologicals for the Treatment of Allergic Diseases and Asthma
Tan, H.-T. T., Sugita, K., & Akdis, C. A. (2016) · Current Allergy and Asthma Reports · doi:10.1007/s11882-016-0650-5 · Cited by 68
Metadata
- Authors
- Schneider, L. C., Rachid, R., LeBovidge, J., Blood, E., Mittal, M., & Umetsu, D. T.
- Venue
- Journal of Allergy and Clinical Immunology
- Publisher
- Elsevier BV
- Published
- 2013-12
- Volume
- 132
- Issue
- 6
- Pages
- 1368-1374
- ISSN
- 0091-6749 (ISSN-L)
- OpenAlex
- W2117748999
- Cited by
- 300
- References
- 37
- FWCI
- 27.83
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.